project id: TCGA-OV; case submitter id: TCGA-29-A5NZ; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.91; age at index: 66; days to birth: -24161; days to death: 1088; ethnicity: not reported; gender: female; race: black or african american; vital status: Dead; year of birth: 1945; year of death: 2013; age at diagnosis: 24161; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 984.0; figo stage: Stage IIIC; icd 10 code: C48.1; last known disease status: not reported; morphology: 8460/3; primary diagnosis: Papillary serous cystadenocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Specified parts of peritoneum; synchronous malignancy: No; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; days to collection: 515; initial weight: 1040.0; sample id: cfa92815-5221-46e2-b7a2-958c556bb390; sample submitter id: TCGA-29-A5NZ-01A; portion id: b0e103fb-82fc-44dd-9a45-35d8b4020b3c; portion submitter id: TCGA-29-A5NZ-01A-11; slide id: f88dabee-0b8b-4c80-990f-36467458ea03; slide submitter id: TCGA-29-A5NZ-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; section location: TOP;